PMGC Holdings ELAB
NASDAQ ELAB
$2.78 -0.03 (-1.06%)
As of: Oct 21, 2026 · 3:47 PM EDT

PMGC Holdings (ELAB) Capital Leases (2026)

Updated

PMGC Holdings' Capital Leases was $274,248 in Q2 2026, unchanged from the prior quarter.

Analysis

PMGC Holdings (ELAB) Capital Leases (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 PMGC Holdings 1.36 Mn -47.00 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 274,248.00
Mar 31, 2026 274,248.00
API Access

PMGC Holdings Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=ELAB&period=max&api_key=YOUR_API_KEY